MCMedicalCodingSoftware
J1574

J1574: Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg

HCPCSActiveBETOS O1E

J1574 is a HCPCS Level II code for injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

The CMS record for J1574

Long descriptor
Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg

The official wording. This is what the code means.

Short descriptor
Inj, ganciclovir (exela)

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2023

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
51: Other

Drugs.

Codes adjacent to J1574

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J1574 is not quite right, the correct code is very often within a few positions of it.

  • J1562Injection, immune globulin (vivaglobin), 100 mgterminated
  • J1566Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
  • J1568Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
  • J1569Injection, immune globulin, (gammagard liquid/gammagard liquid erc), 500 mg
  • J1570Injection, ganciclovir sodium, 500 mg
  • J1571Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml
  • J1572Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg
  • J1573Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
  • J1575Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
  • J1576Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg
  • J1577Injection, immune globulin (qivigy), 100 mg
  • J1580Injection, garamycin, gentamicin, up to 80 mg
  • J1590Injection, gatifloxacin, 10 mgterminated
  • J1595Injection, glatiramer acetate, 20 mg
  • J1596Injection, glycopyrrolate, 0.1 mg
  • J1597Injection, glycopyrrolate (glyrx-pf), 0.1 mg
HCPCS Level II2026Q4-Oct· effective October 1, 2026